Mizoribine oral pulse therapy for a patient with severe lupus nephritis.
Tanaka
Hiroshi
H
Department of Pediatrics, Hirosaki University, School of Medicine, Hirosaki, Japan. hirotana@cc.hirosaki-u.ac.jp
Suzuki
Koichi
K
Nakahata
Tohru
T
Sato
Tomohiko
T
Ito
Etsuro
E
D000284:Administration, Oral; D002648:Child; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008181:Lupus Nephritis / Q000188:drug therapy*; D012263:Ribonucleosides / Q000008:administration & dosage*; D012720:Severity of Illness Index
D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine